How current biologic therapies affect the risk of major adverse cardiovascular events in patients with plaque psoriasis? A systematic review and meta-analysis of randomized controlled trials

How current biologic therapies affect the risk of major adverse cardiovascular events in patients with plaque psoriasis? A systematic review and meta-analysis of randomized controlled trials

Bibliographic Details
Main Authors:	Sonia Nartowicz, Ewelina Jakielska, Monika Priadka, Zygmunt Adamski, Piotr Ratajczak, Krzysztof Kus
Format:	Article
Language:	English
Published:	Termedia Publishing House 2021-01-01
Series:	Advances in Dermatology and Allergology
Subjects:	psoriasis biologic therapies major adverse cardiac events
Online Access:	https://www.termedia.pl/How-current-biologic-therapies-affect-the-risk-of-major-adverse-cardiovascular-events-in-patients-with-plaque-psoriasis-A-systematic-review-and-meta-analysis-of-randomized-controlled-trials,7,42831,1,1.html

Similar Items

Contemporary treatment patterns in plaque psoriasis and psoriatic arthritis
by: Dorota Jenerowicz, et al.
Published: (2020-04-01)

Childhood trauma: a risk for major depression in patients with psoriasis
by: Mercede Erfanian
Published: (2018-10-01)

Adverse reactions of biological therapies in patients with psoriasis
by: Maria I. Sârbu, et al.
Published: (2017-04-01)

Olanzapine-induced Psoriasis
by: Ashish Hanmantrao Chepure, et al.
Published: (2017-01-01)

Failure of response to combination therapy of adalimumab and infliximab in a recalcitrant patient of severe psoriasis and major thalassemia: A case report
by: Mohamad Goldust, et al.
Published: (2020-03-01)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
by: Gisondi P, et al.
Published: (2016-05-01)

Hematological, hepatic, and renal adverse effects of high dose methotrexate injection (50 mg weekly) in severe psoriasis cases
by: Adissa Tiara Yulinvia, et al.
Published: (2019-03-01)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
by: Meifan Zheng, et al.
Published: (2020-06-01)

Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
by: Nicole L. Bolick, et al.
Published: (2020-12-01)

Association of Streptococcus with Plaque Type of Psoriasis
by: Mohammad Akram Hossain, et al.
Published: (2015-05-01)

The use of complementary and alternative medicine by patients suffering from psoriasis and psoriatic arthritis
by: Aleksandra Wnuk-Kłosińska, et al.
Published: (2020-10-01)

Biological therapy of psoriasis
by: Sivamani Raja, et al.
Published: (2010-01-01)

Secukinumab for plaque psoriasis
by: Gonzalo Ordenes-Cavieres, et al.
Published: (2018-11-01)

Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice
by: Savannah D. Neu, et al.
Published: (2021-08-01)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
by: Zhihao Chen, et al.
Published: (2018-11-01)

Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks
by: Paolo Gisondi, et al.
Published: (2020-11-01)

Bacterial colonization of psoriasis plaques. Is it relevant?
by: Eva Marcus, et al.
Published: (2011-08-01)

Treating pediatric plaque psoriasis: challenges and solutions
by: Thomas J, et al.
Published: (2016-04-01)

Multiple keratoacanthomas developing in healing plaques of Psoriasis
by: Vineet Relhan, et al.
Published: (2013-01-01)

Evaluation of intralesional 5% 5-fluorouracil in resistant localized plaque psoriasis
by: Bharat Bhushan Mahajan, et al.
Published: (2014-01-01)

Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis
by: Yan-yan Qi, et al.
Published: (2021-01-01)

Development of Dermatitis Herpetiformis in Chronic Plaque Psoriasis
by: Ruby Lee, et al.
Published: (2021-02-01)

The content validity of the PSS in patients with plaque psoriasis
by: A. M. Rentz, et al.
Published: (2017-09-01)

Stigma experienced by the caregivers of patients with chronic plaque psoriasis
by: Sandeep Grover, et al.
Published: (2021-01-01)

Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
by: Martina Burlando, et al.
Published: (2021-05-01)

Psoriasis in special localizations
by: Klaudia Dopytalska, et al.
Published: (2018-12-01)

Generalized Severe Plaque Psoriasis in an HIV Positive Patient – a Challenging Treatment
by: Chiriac Anca, et al.
Published: (2017-03-01)

Profile of Psoriasis Vulgaris Patients Treated with Methotrexate at Dr. Soetomo Hospital, Surabaya, 2017–2018
by: Damayanti Damayanti, et al.
Published: (2021-01-01)

Risk of major adverse cardiovascular and cerebrovascular events in Taiwanese women with endometriosis
by: Hsin-Ju Chiang, et al.
Published: (2021-01-01)

Histone Deacetylase 1 and Sirtuin 1 Expression in Psoriatic Skin: A Comparison between Guttate and Plaque Psoriasis
by: Young-Ji Hwang, et al.
Published: (2020-08-01)

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
by: Alessio Gambardella
Published: (2019-09-01)

Sonographic evaluation of subclinical enthesopathy in patients of chronic plaque psoriasis
by: Kapil Vyas, et al.
Published: (2020-01-01)

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
by: Wen-Jun Tu, et al.
Published: (2020-08-01)

New possibilities of systemic therapy of plaque psoriasis with the IL23p19 inhibitor risankizumab
by: O. V. Zhukova, et al.
Published: (2021-06-01)

The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis
by: Schmitt, Jochen, et al.
Published: (2014)

Treatment of psoriasis vulgaris: guidelines of experts of the Polish Dermatological Society. Part II: moderate to severe psoriasis
by: Jacek Szepietowski, et al.
Published: (2014-11-01)

Real-world insight on apremilast therapy in patients with plaque psoriasis: Indian experience
by: Abhishek De, et al.
Published: (2020-01-01)

Treatment challenges in the management of moderate-to-severe plaque psoriasis – role of secukinumab
by: Malakouti M, et al.
Published: (2016-10-01)

Efficacy of adding topical simvastatin to topical calcipotriol on improvement of cutaneous plaque psoriasis
by: Fariba Iraji, et al.
Published: (2014-01-01)